Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer

IR (HANDLE) Open Access
  • KAGEYAMA, Yukio
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • KIHARA, Kazunori
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • KAMATA, Shigeyoshi
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • NAGAHAMA, Katsushi
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • YONESE, Junji
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • FUKUDA, Hiroshi
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • TOSAKA, Akira
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • NAGAMATSU, Hideki
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • ISHIZAKA, Kazuhiro
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • TSUJII, Toshihiko
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • KITAHARA, Satoshi
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • MORITA, Takashi
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine
  • OSHIMA, Hiroyuki
    the Department of Urology, Tokyo Medicaland Dental Univerity School of Medicine

Bibliographic Information

Other Title
  • 未治療前立腺癌における治療前PSA値と骨転移との関係

Search this article

Description

We retrospectively reviewed pretreatment levels of serum prostate specific antigen (PSA) in 138 newly diagnosed, untreated patients with prostate adenocarcinoma to evaluate the usefulness of serum PSA levels to predict results of radionuclide bone scans. All of the 24 patients with serum PSA levels above 200 ng/ml showed positive bone scans whereas those with serum PSA levels below 10 ng/ml included only three cases (3/51, 5.1%) positive for bone metastasis. All of the three had poorly differentiated adenocarcinoma of the prostate. In conclusion, bone scans may not be necessary in the cases with serum PSA levels less than 10 ng/ml except for those with poorly differentiated adenocarcinoma.

Journal

  • Hinyokika Kiyo

    Hinyokika Kiyo 42 (3), 197-199, 1996-03

    泌尿器科紀要刊行会

Keywords

Details 詳細情報について

Report a problem

Back to top